Comparison of Short-Term Outcomes between Button-Type Bipolar Plasma Vaporization and Transurethral Resection for the Prostate: A Systematic Review and Meta-Analysis

Xiaonan Zheng, Xin Han, Dehong Cao, Yaping Wang, Hang Xu, Lu Yang, Qiang Wei, Jianzhong Ai, Xiaonan Zheng, Xin Han, Dehong Cao, Yaping Wang, Hang Xu, Lu Yang, Qiang Wei, Jianzhong Ai

Abstract

Background: Previous meta-analysis evaluated a limited number of parameters regarding the comparison of BTPV and TURP for BPH. Method: PubMed, Embase and Cochrane Library were searched for literature comparing BTPV with TURP. Data of efficacy (IPSS, Qmax, PVR and QoL) and safety were extracted and evaluated using either SMD or OR with 95% CI. All analyses were performed by RevMan 5.3. Results: Eleven trials with 1690 patients were selected. Compare to BTPV, TURP had better 6-month IPSS (SMD=0.36, 95% CI 0.08 to 0.63), better 1- (SMD=-0.38, 95% CI -0.63 to -0.12), 6- (SMD=-0.73, 95% CI -0.99 to -0.46) and 12-month Qmax (SMD=-0.47, 95% CI -0.85 to -0.10), better 6-month PVR (SMD=1.18, 95% CI 0.87 to 1.48), as well as better 3- (SMD=-0.24, 95% CI -0.48 to -0.01) and 6-month QoL (SMD=-0.62, 95% CI -0.91 to -0.33). However, BTPV had shorter catheterization time (SMD=-0.96, 95% CI -1.12 to -0.79) and hospital stay (SMD=-0.71, 95% CI -0.89 to -0.53), less hemoglobin decrease (SMD=-1.09, 95% CI -1.27 to -0.91) and virtually shorter operation time (SMD=-0.15, 95% CI -0.31 to 0.01). Moreover, BTPV had fewer occurrence of overall complications (OR=0.52, 95% CI 0.40 to 0.69), Clavien III-IV complications (OR=0.61, 95% CI 0.37 to 1.02), blood transfusion (OR=0.25, 95% CI 0.09 to 0.69), hematuria (OR=0.27, 95% CI 0.13 to 0.56) and capsular perforation (OR=0.19, 95% CI 0.08 to 0.48). Subgroup analysis indicated BTPV and bipolar TURP had similar total complications (OR 1.08, 95% CI 0.40-2.88, P=0.88) and Clavien III-IV complications (OR 1.42, 95% CI 0.36-5.57, P=0.61) and blood transfusion rate (OR 0.28, 95% CI 0.04-1.73, P=0.17). Conclusion: Both TURP and BTPV could significantly improve IPPS, Qmax, PVR and QoL. TURP had slightly better short-term efficacy, while BTPV had better safety. However, subgroup analysis found bipolar TURP and BTPV had similar safety.

Keywords: benign prostatic hyperplasia (BPH); button-type bipolar plasma vaporization (BTPV); lower urinary tract symptoms (LUTS); transurethral resection (TURP).

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

© The author(s).

Figures

Figure 1
Figure 1
PRISMA flowchart of study selection.
Figure 2
Figure 2
IPSS and Qmax after treatment. A. IPSS; B. Qmax
Figure 3
Figure 3
PVR and QoL after treatment. A. PVR; B. QoL
Figure 4
Figure 4
Complications.
Figure 5
Figure 5
Other intraoperative and postoperative parameters.

References

    1. Chapple C. & Abrams P. E. Société Internationale d'Urologie (SIU), Lower Urinary Tract Symptoms (LUTS): An International Consultation on Male LUTS; 2013.
    1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U. et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49.
    1. Kupelian V, Wei JT, O'Leary MP, Kusek JW, Litman HJ, Link CL. et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Archives of internal medicine. 2006;166:2381–7.
    1. EAU Guidelines. Edn. presented at the EAU Annual Congress Barcelona; 2019. ISBN 978-94-92671-04-2.
    1. Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F. et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. European urology. 2010;58:384–97.
    1. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU international. 1999;83:227–37.
    1. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P. et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. The Journal of urology. 2008;180:246–9.
    1. Bucuras V, Bardan R. Bipolar vaporization of the prostate: is it ready for the primetime? Therapeutic advances in urology. 2011;3:257–61.
    1. Reich O, Schlenker B, Gratzke C, Tilki D, Riecken M, Stief C. et al. Plasma vaporisation of the prostate: initial clinical results. European urology. 2010;57:693–7.
    1. Wroclawski ML, Carneiro A, Amarante RD, Oliveira CE, Shimanoe V, Bianco BA. et al. 'Button type' bipolar plasma vaporisation of the prostate compared with standard transurethral resection: a systematic review and meta-analysis of short-term outcome studies. BJU international. 2016;117:662–8.
    1. Aboutaleb H. Efficacy of bipolar "button" plasma vaporization of the prostate for benign prostatic obstruction, compared to the standard technique. Urology annals. 2015;7:442–7.
    1. Elsakka AM, Eltatawy HH, Almekaty KH, Ramadan AR, Gameel TA, Farahat Y. A prospective randomised controlled study comparing bipolar plasma vaporisation of the prostate to monopolar transurethral resection of the prostate. Arab journal of urology. 2016;14:280–6.
    1. Falahatkar S, Mokhtari G, Moghaddam KG, Asadollahzade A, Farzan A, Shahab E. et al. Bipolar transurethral vaporization: a superior procedure in benign prostatic hyperplasia: a prospective randomized comparison with bipolar TURP. International braz j urol: official journal of the Brazilian Society of Urology. 2014;40:346–55.
    1. Geavlete B, Georgescu D, Multescu R, Stanescu F, Jecu M, Geavlete P. Bipolar plasma vaporization vs monopolar and bipolar TURP-A prospective, randomized, long-term comparison. Urology. 2011;78:930–5.
    1. Geavlete B, Multescu R, Dragutescu M, Jecu M, Georgescu D, Geavlete P. Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standard TUR of the prostate: 'the better choice' in benign prostatic hyperplasia? BJU international. 2010;106:1695–9.
    1. Geavlete B, Stanescu F, Moldoveanu C, Geavlete P. Continuous vs conventional bipolar plasma vaporisation of the prostate and standard monopolar resection: a prospective, randomised comparison of a new technological advance. BJU international. 2014;113:288–95.
    1. Nuhoglu B, Balci MB, Aydin M, Hazar I, Onuk O, Tas T. et al. The role of bipolar transurethral vaporization in the management of benign prostatic hyperplasia. Urologia internationalis. 2011;87:400–4.
    1. Kranzbuhler B, Gross O, Fankhauser CD, Wettstein MS, Grossmann NC, Hefermehl LJ. et al. Prostate volume reduction following pure transurethral bipolar plasma vaporization and conventional transurethral resection of the prostate: a prospective investigation using transrectal 3D ultrasound volumetry. World journal of urology. 2017;35:429–35.
    1. Yip SK, Chan NH, Chiu P, Lee KW, Ng CF. A randomized controlled trial comparing the efficacy of hybrid bipolar transurethral vaporization and resection of the prostate with bipolar transurethral resection of the prostate. Journal of endourology. 2011;25:1889–94.
    1. Zhang SY, Hu H, Zhang XP, Wang D, Xu KX, Na YQ. et al. Efficacy and safety of bipolar plasma vaporization of the prostate with "button-type" electrode compared with transurethral resection of prostate for benign prostatic hyperplasia. Chinese medical journal. 2012;125:3811–4.
    1. Geavlete B, Bulai C, Ene C, Checherita I, Geavlete P. Bipolar vaporization, resection, and enucleation versus open prostatectomy: optimal treatment alternatives in large prostate cases? Journal of endourology. 2015;29:323–31.
    1. Madersbacher S, Lackner J, Brossner C, Rohlich M, Stancik I, Willinger M. et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. European urology. 2005;47:499–504.
    1. Robert G, de la Taille A, Herrmann T. Bipolar plasma vaporization of the prostate: ready to replace GreenLight? A systematic review of randomized control trials. World journal of urology. 2015;33:549–54.
    1. Torres Castellanos L, Moreno Bencardino MC, Bravo-Balado A, Garcia Mayorga CA, Vargas Manrique I, Fernandez N. Evaluation of the Efficacy and Safety of Laser versus Cold Knife Urethrotomy in the Management of Patients with Urethral Strictures: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Urologia internationalis. 2017;99:453–9.
    1. Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. European urology. 2009;56:798–809.
    1. Omar MI, Lam TB, Alexander CE, Graham J, Mamoulakis C, Imamura M. et al. Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP) BJU international. 2014;113:24–35.
    1. Inzunza G, Rada G, Majerson A. Bipolar or monopolar transurethral resection for benign prostatic hyperplasia? Medwave. 2018;18:e7134.
    1. Stucki P, Marini L, Mattei A, Xafis K, Boldini M, Danuser H. Bipolar versus monopolar transurethral resection of the prostate: a prospective randomized trial focusing on bleeding complications. The Journal of urology. 2015;193:1371–5.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi